The vascular perspective of systemic sclerosis: Of chickens, mice and men

International Archives of Allergy and Immunology

Volumn 120, Issue 3, 1999, Pages 169-176

  Sgonc, R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Adhesion molecules; Anti endothelial cell antibodies; Apoptosis; Cytokines; Endothelial cells; Scleroderma

Indexed keywords

ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; CELL INFILTRATION; CHICKEN; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

EID: 0032752728     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024264     Document Type: Review

References (66)

1. Krieg T, Meurer M: Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1988;18:457-481.
2. LeRoy EC, Trojanowska M, Smith EA: The pathogenesis of scleroderma (systemic sclerosis, SSc). Clin Exp Rheumatol 1991;9:173-177.
3. Black CM: The aetiopathogenesis of systemic sclerosis. J Intern Med 1993;234:3-8.
4. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nuclear antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988;31:525-532.
5. Famularo G, Giacomelli R, Alesse E, Cifone MG, Morrone S, Boirivant M, Danese C, Perego MA, Santoni A, Tonietti G: Polyclonal B lymphocyte activation in progressive systemic sclerosis. J Clin Lab Immunol 1989;29:59-63.
6. White B: Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 1996;22:695-708.
7. Gruschwitz MS, Albrecht M, Vieth G, Haustein UF: In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis. J Rheumatol 1997;24:1936-1943.
8. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992;166:255-263.
9. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G: Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996;98:785-792.
10. Russell ML: The tight-skin mouse: Is it a model for scleroderma? J Rheumatol 1983;10:679-688.
11. Peters J, Ball ST: Tight skin-2 (Tsk2). Mouse News Lett 1986;74:91-92.
12. Gershwin ME, Abplanalp H, Castles RM, Ikeda J, Van De Water J, Eklund J, Haynes D: Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma). J Exp Med 1981;153:1640-1659.
13. Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ, Buchberg AM, Jimenez SA: A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996;6:300-313.
14. Bocchieri MJ, Henriksen PD, Kasturi KN, Muryoi T, Bona CA, Jimenez SA: Evidence for autoimmunity in tight skin (TSK/+) mouse model of progressive systemic sclerosis. Arthritis Rheum 1991;34:599-605.
15. Christner PJ, Peters J, Hawkins D, Siracusa LD, Jimenez SA: The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum 1995;38:1791-1798.
16. Gruschwitz MS, Shoenfeld Y, Krupp M, Gershwin ME, Penner E, Brezinschek H-P, Wick G: Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis. Int Arch Allergy Immunol 1993;100:307-313.
17. Sgonc R, Wick G: What can we learn from an avian model for scleroderma? in Schoenfeld Y (ed): The Decade of Autoimmunity. Amsterdam, Elsevier, 1999, pp 209-217.
18. Wick G, Sgonc R, Kroemer G: Autoimmune disease, spontaneous animal models; in Delves PJ, Roitt IM (eds): Encyclopedia of Immunology. London, Academic Press, 1998, pp 280-287.
19. Gruschwitz MS, Moormann S, Kromer G, Sgonc R, Dietrich H, Boeck G, Gershwin ME, Boyd R, Wick G: Phenotypic analysis of skin infiltrates in comparison with peripheral blood lymphocytes, spleen cells and thymocytes in early avian scleroderma. J Autoimmun 1991;4:577-593.
20. Ausserlechner MJ, Sgonc R, Dietrich H, Wick G: Altered procollagen mRNA expression during the progression of avian scleroderma. Mol Med 1997;3:654-662.
21. Sgonc R, Dietrich H, Gershwin ME, Colombatti A, Wick G: Genomic analysis of collagen and endogenous virus loci in the UCD-200 and 206 lines of chickens, animal models for scleroderma. J Autoimmun 1995;8:763-770.
22. Campbell PM, LeRoy EC: Pathogenesis of systemic sclerosis: A vascular hypothesis. Semin Arthritis Rheum 1975;4:351-368.
23. Kahaleh MB, Osborn I, LeRoy EC: Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med 1981;94:482-484.
24. Blann AD, Illingworth K, Jayson MI: Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993;20:1325-1330.
25. Belch JJ, McLaren M, Anderson J, Lowe GD, Sturrock RD, Capell HA, Forbes CD: Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukotrienes Med 1985;17:1-9.
26. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N: Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol 1994;101:109-113.
27. Matucci Cerinic M, Jaffa A, Kahaleh B: Angiotensin converting enzyme: An in vivo and in vitro marker of endothelial injury. J Lab Clin Med 1992;120:428-433.
28. Reilly IA, Roy L, Fitzgerald GA: Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J Clin Res Ed 1986;292:1037-1039.
29. Kahaleh MB, Osborn I, LeRoy EC: Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Ann Intern Med 1982;96:610-613.
30. Sgonc R, Dietrich H, Sieberer C, Wick G, Christner PJ, Jimenez SA: Lack of endothelial cell apoptosis in the dermis of tight skin 1 and tight skin 2 mice. Arthritis Rheum 1999;42:581-584.
31. Kahaleh MB, Fan PS: Mechanism of serum-mediated endothelial injury in scleroderma: Identification of a granular enzyme in scleroderma skin and sera. Clin Immunol Immunopathol 1997;83:32-40.
32. Sgonc R, Boeck G, Gruschwitz M, Sepp N, Wick G: Endothelial cell apoptosis in systemic sclerosis is induced by antibody dependent cellular cytotoxicity via CD95 (abstract). J Rheumatol 1998;25(suppl 52):76.
33. Marks RM, Czerniecki M, Andrews BS, Penny R: The effects of scleroderma serum on human microvascular entothelial cells. Induction of antibody-dependent cellular cytotoxicity. Arthritis Rheum 1988;31:1524-1534.
34. Holt CM, Lindsey N, Moult J, Malia RG, Greaves M, Hume A, Rowell NR, Hughes P: Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol 1989;78:359-365.
35. Hitraya EG, Tan EM, Rudnicka L, Jimenez SA: Expression of extracellular matrix genes in adult human dermal microvascular endothelial cells and their regulation by heparin and endothelial cell mitogens. Lab Invest 1995;73:393-402.
36. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY: The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998;101:2029-2035.
37. Del Papa N, Conforti G, Gambini D, La Rosa L, Tincani A, D'Cruz D, Khamashta M, Hughes GR, Balestrieri G, Meroni PL: Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-216.
38. Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, Pearson JD: Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-456.
39. Salojin KV, Le Tonquèze M, Saraux A, Nassonov EL, Dueymes M, Piette JC, Youinou PY: Antiendothelial cell antibodies: Useful markers of systemic sclerosis. Am J Med 1997;102:178-185.
40. Renaudineau Y, Revelen R, Levy Y, Salojin K, Gilburg B, Shoenfeld Y, Youinou P: Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 1999;6:156-160.
41. Pignone A, Scaletti C, Matucci Cerinic M, Vazquez Abad D, Meroni PL, Del Papa N, Falcini F, Generini S, Rothfield N, Cagnoni M: Anti-endothelial cell antibodies in systemic sclerosis: Significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998;16:527-532.
42. Carvalho D, Savage CO, Black CM, Pearson JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996;97:111-119.
43. Gruschwitz M, von den Driesch P, Kellner I, Hornstein OP, Sterry W: Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol 1992;27:169-177.
44. Sollberg S, Peltonen J, Uitto J, Jimenez SA: Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 1992;35:290-298.
45. Carvalho D, Savage CO, Isenberg D, Pearson JD: IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999;42:631-640.
46. Gruschwitz MS, Vieth G: Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum 1997;40:540-550.
47. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells [see comments]. Nature 1991;349:796-799.
48. Claman HN, Giorno RC, Seibold JR: Endothelial and fibroblastic activation in scleroderma. The myth of the 'uninvolved skin'. Arthritis Rheum 1991;34:1495-1501.
49. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP: Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-760.
50. Reiss Y, Hoch G, Deutsch U, Engelhardt B: T cell interaction with ICAM-1-deficient endothelium in vitro: Essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur J Immunol 1998;28:3086-3099.
51. Hynes RO: Integrins: A family of cell surface receptors. Cell 1987;48:549-554.
52. Koch AE, Kronfeld Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, Strieter RM, Kunkel SL, Massa MC, Barr WG, et al: In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993;61:239-246.
53. Gruschwitz MS, Hornstein OP, von den Driesch P: Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995; 38:184-189.
54. Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO, Dubois RM, Black CM: Serial circulating adhesion molecules levels reflect disease severity in systemic sclerosis. Br J Rheumatol 1995;34:1048-1054.
55. Kahaleh MB: Endothelin, an endothelial-dependent vascoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991;34:978-983.
56. Yamane K, Miyauchi T, Suzuki N, Yuhara T, Akama T, Suzuki H, Kashiwagi H: Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol 1992;19:1566-1571.
57. Gruschwitz M, Muller PU, Sepp N, Hofer E, Fontana A, Wick G: Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis? J Invest Dermatol 1990; 94:197-203.
58. Gabrielli A, Di Loreto C, Taborro R, Candela M, Sambo P, Nitti C, Danieli MG, DeLustro F, Dasch JR, Danieli G: Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol 1993;68:340-349.
59. Takehara K, LeRoy EC, Grotendorst GR: TGF-beta inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 1987;49:415-422.
60. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al: Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
61. Varga J, Rosenbloom J, Jimenez SA: Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987;247:597-604.
62. Van Snick J: Interleukin-6: An overview. Annu Rev Immunol 1990;8:253-278.
63. Duncan MR, Berman B: Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991;97:686-692.
64. Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-2020.
65. Hasegawa M, Sato S, Takehara K: Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1-alpha) and MIP-1-(beta) in patients with systemic sclerosis: MCP-1 and MIP-1-alpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999;117:159-165.
66. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994;10:41-42.